KKR Genetic Disorder L.P.

CIK 1780408 · last filed 2025-03-07

KKR Genetic Disorder L.P. is a corporate insider who has filed 1 SEC Form 4 insider transactions across 1 company since 2025. The most recent filing shows the insider sold $1.78B of BBIO on Mar 7, 2025. Across all open-market trades the lifetime net is −$1.78B, making them a net seller over the disclosed history. Current disclosed insider exposure totals $1.29B across reported positions.

"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.

Disclosed Exposure

$1.29B

Companies

1

Total Filings

1

Lifetime Open-Market Net

-$1.78B

Holdings By Company

Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.

Symbol	Role	Shares	Price	Disclosed Exposure	Lifetime OM Net	Filings	Latest Filed
BBIO	10%+ Owner	19,260,971	$66.80	$1.29B	-$1.78B	1	2025-03-07

Recent Filings

1 filing

Form 4 transactions across all companies, newest first.

Filed	Symbol	Action	Net Shares	Net $	Link
2025-03-07	BBIO	Sell (S)	−54,000,000	-$1.78B	EDGAR

Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.